Related Articles
The PI3K/Akt inhibitor LY294002 reverses BCRP-mediated drug resistance without affecting BCRP translocation
Combination of SN-38 with gefitinib or imatinib overcomes SN-38-resistant small-cell lung cancer cells
Cooperative effect of gefitinib and fumitremorgin c on cell growth and chemosensitivity in estrogen receptor α negative fulvestrant-resistant MCF-7 cells
Ponatinib enhances anticancer drug sensitivity in MRP7-overexpressing cells
Breast cancer resistance protein (BCRP)‑containing circulating microvesicles contribute to chemoresistance in breast cancer